Psoriasis : : New Research / / Shahin Aghaei.

Psoriasis is a chronic skin disease that starts with lesions that appear red, thick, scaly, and itchy with bilateral and symmetrical distribution. The lesions are most often seen in the scalp, elbows, knees, and genitalia. The extent of the lesions is not always limited to these areas, and in some c...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Place / Publishing House:London : : IntechOpen,, 2022.
Year of Publication:2022
Language:English
Physical Description:1 online resource (198 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993581452604498
ctrlnum (CKB)5700000000338619
(NjHacI)995700000000338619
(EXLCZ)995700000000338619
collection bib_alma
record_format marc
spelling Aghaei, Shahin, author.
Psoriasis : New Research / Shahin Aghaei.
Psoriasis
London : IntechOpen, 2022.
1 online resource (198 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on online resource; title from PDF title page (IntechOpen, viewed March 25, 2023).
Psoriasis is a chronic skin disease that starts with lesions that appear red, thick, scaly, and itchy with bilateral and symmetrical distribution. The lesions are most often seen in the scalp, elbows, knees, and genitalia. The extent of the lesions is not always limited to these areas, and in some cases, it may involve larger parts of the skin, as well as nails and joints in some cases. This book presents a comprehensive overview of psoriasis, including clinical aspects, differential diagnosis by dermoscopic devices, comorbidities, immune system changes, methotrexate therapy, and topical innovative molecular targeted therapeutics.
1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis.
Psoriasis.
1-80355-375-8
language English
format eBook
author Aghaei, Shahin,
spellingShingle Aghaei, Shahin,
Psoriasis : New Research /
1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis.
author_facet Aghaei, Shahin,
author_variant s a sa
author_role VerfasserIn
author_sort Aghaei, Shahin,
title Psoriasis : New Research /
title_sub New Research /
title_full Psoriasis : New Research / Shahin Aghaei.
title_fullStr Psoriasis : New Research / Shahin Aghaei.
title_full_unstemmed Psoriasis : New Research / Shahin Aghaei.
title_auth Psoriasis : New Research /
title_alt Psoriasis
title_new Psoriasis :
title_sort psoriasis : new research /
publisher IntechOpen,
publishDate 2022
physical 1 online resource (198 pages)
contents 1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis.
isbn 1-80355-376-6
1-80355-375-8
callnumber-first R - Medicine
callnumber-subject RL - Dermatology
callnumber-label RL321
callnumber-sort RL 3321 S534 42022
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.52606
dewey-sort 3616.52606
dewey-raw 616.52606
dewey-search 616.52606
work_keys_str_mv AT aghaeishahin psoriasisnewresearch
AT aghaeishahin psoriasis
status_str n
ids_txt_mv (CKB)5700000000338619
(NjHacI)995700000000338619
(EXLCZ)995700000000338619
carrierType_str_mv cr
is_hierarchy_title Psoriasis : New Research /
_version_ 1764995748692230144
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02095nam a2200301 i 4500</leader><controlfield tag="001">993581452604498</controlfield><controlfield tag="005">20230326220034.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230326s2022 enk o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-80355-376-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5700000000338619</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995700000000338619</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995700000000338619</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RL321</subfield><subfield code="b">.S534 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.52606</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Aghaei, Shahin,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Psoriasis :</subfield><subfield code="b">New Research /</subfield><subfield code="c">Shahin Aghaei.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Psoriasis </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (198 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (IntechOpen, viewed March 25, 2023).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Psoriasis is a chronic skin disease that starts with lesions that appear red, thick, scaly, and itchy with bilateral and symmetrical distribution. The lesions are most often seen in the scalp, elbows, knees, and genitalia. The extent of the lesions is not always limited to these areas, and in some cases, it may involve larger parts of the skin, as well as nails and joints in some cases. This book presents a comprehensive overview of psoriasis, including clinical aspects, differential diagnosis by dermoscopic devices, comorbidities, immune system changes, methotrexate therapy, and topical innovative molecular targeted therapeutics.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Psoriasis.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-80355-375-8</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 13:11:23 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-12-05 16:10:45 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5343023870004498&amp;Force_direct=true</subfield><subfield code="Z">5343023870004498</subfield><subfield code="8">5343023870004498</subfield></datafield></record></collection>